RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BITOSSI R
Collezione AOU San Luigi di Orbassano

Items : 13

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.

2012
AOU San Luigi di Orbassano

Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;

Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.

2008
AOU San Luigi di Orbassano

Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;

Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2007 Oct;133(10):783-5. doi: 10.1007/s00432-007-0234-9. Epub 2007 Jun 6.

2007
AOU San Luigi di Orbassano

Tampellini M; Brizzi MP; Bitossi R; Alabiso I; Sculli CM; Chiusa L; Papotti M; Dogliotti L;

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.

2006
AOU San Luigi di Orbassano

Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.

2006
AOU San Luigi di Orbassano

Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.

2006
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.

2005
AOU San Luigi di Orbassano

Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;

Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study. in Tumori / Tumori. 2004 Jan-Feb;90(1):44-9. doi: 10.1177/030089160409000111.

2004
AOU San Luigi di Orbassano

Tampellini M; Bitossi R; Brizzi MP; Saini A; Tucci M; Alabiso I; Dogliotti L;

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.

2002
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;

Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.

2001
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. in The Journal of urology / J Urol. 2000 Oct;164(4):1248-53.

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;